Similar articles

• Can single-patient investigational new drug studies hurry slow trains to the fast track?

  Chenoweth D. Chenoweth D. Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4. Drug Discov Today. 2006. PMID: 16580594
• Cancer and AIDS groups push for changes in drug approval process.

  Anderson LF. Anderson LF. J Natl Cancer Inst. 1989 Jun 7;81(11):829-31. J Natl Cancer Inst. 1989. PMID: 2724348 No abstract available.
• Expanded availability of dideoxyinosine (ddI) for AIDS.

  [No authors listed] [No authors listed] J Am Osteopath Assoc. 1989 Dec;89(12):1507-8, 1511. J Am Osteopath Assoc. 1989. PMID: 2516079 Clinical Trial. No abstract available.
• Drug approval and AIDS: benefits for the elderly.

  Rothman DJ, Edgar H. Rothman DJ, et al. Health Aff (Millwood). 1990 Fall;9(3):123-30. doi: 10.1377/hlthaff.9.3.123. Health Aff (Millwood). 1990. PMID: 2227773 Review. No abstract available.
• Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.

  Carter SK, Slavik M. Carter SK, et al. Natl Cancer Inst Monogr. 1977 Mar;(45):101-21. Natl Cancer Inst Monogr. 1977. PMID: 73134 Review. No abstract available.